244 related articles for article (PubMed ID: 8635027)
1. Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma.
Baer SC; Schultz D; Synnestvedt M; Elder DE
Cancer; 1995 Dec; 76(11):2242-7. PubMed ID: 8635027
[TBL] [Abstract][Full Text] [Related]
2. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
[TBL] [Abstract][Full Text] [Related]
4. Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.
Haydu LE; Stollman JT; Scolyer RA; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Bonenkamp JJ; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1071-81. PubMed ID: 25956574
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous melanomas exhibiting unusual biologic behavior.
Shaw HM; Rivers JK; McCarthy SW; McCarthy WH
World J Surg; 1992; 16(2):196-202. PubMed ID: 1561799
[TBL] [Abstract][Full Text] [Related]
6. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in thin cutaneous malignant melanoma.
Månsson-Brahme E; Carstensen J; Erhardt K; Lagerlöf B; Ringborg U; Rutqvist LE
Cancer; 1994 May; 73(9):2324-32. PubMed ID: 8168037
[TBL] [Abstract][Full Text] [Related]
9. Neurotropism as a prognostic factor in cutaneous melanoma patients.
Tas F; Erturk K
Neoplasma; 2018; 65(2):304-308. PubMed ID: 29534593
[TBL] [Abstract][Full Text] [Related]
10. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of prognostic indicators for early recurrence of cutaneous melanoma.
Matheson JA; Te Marvelde L; Mailer S; Speakman D; Spillane J; Henderson MA; Gyorki DE
Melanoma Res; 2017 Feb; 27(1):43-49. PubMed ID: 27753732
[TBL] [Abstract][Full Text] [Related]
12. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
13. Staging and prognosis of melanoma.
Brown M
Semin Cutan Med Surg; 1997 Jun; 16(2):113-21. PubMed ID: 9220550
[TBL] [Abstract][Full Text] [Related]
14. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
15. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
Urist MM; Balch CM; Soong S; Shaw HM; Milton GW; Maddox WA
Cancer; 1985 Mar; 55(6):1398-402. PubMed ID: 3971310
[TBL] [Abstract][Full Text] [Related]
16. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
Tas F; Keskin S; Karadeniz A; Dağoğlu N; Sen F; Kilic L; Yildiz I
Oncology; 2011; 81(5-6):353-8. PubMed ID: 22248874
[TBL] [Abstract][Full Text] [Related]
17. Wide excision without radiation for desmoplastic melanoma.
Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in primary cutaneous malignant melanoma.
Sondergaard K; Schou G
Am J Dermatopathol; 1985; 7 Suppl():1-4. PubMed ID: 3940069
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
20. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]